Skip to main content

Published locations for Dose-adjusted EPOCH and rituximab beneficial for selected older patients with high-risk DLBCL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dose-adjusted EPOCH and rituximab beneficial for selected older patients with high-risk DLBCL

User login

  • Reset your password
  • /content/dose-adjusted-epoch-and-rituximab-beneficial-selected-older-patients-high-risk-dlbcl
  • /hematology-oncology/article/262411/b-cell-lymphoma/dose-adjusted-epoch-and-rituximab-beneficial
  • /b-cell-lymphoma-icymi/article/262411/b-cell-lymphoma/dose-adjusted-epoch-and-rituximab-beneficial